Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer
NCT02851381
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
The patient passed before treatment could be started
Conditions
Pancreatic Cancer
Interventions
DRUG:
FG-3019
Sponsor
Jonsson Comprehensive Cancer Center